KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) EBT Margin (2016 - 2025)

Historic EBT Margin for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to 15.35%.

  • Amgen's EBT Margin rose 67400.0% to 15.35% in Q4 2025 from the same period last year, while for Dec 2025 it was 24.42%, marking a year-over-year increase of 106300.0%. This contributed to the annual value of 24.42% for FY2025, which is 106300.0% up from last year.
  • Latest data reveals that Amgen reported EBT Margin of 15.35% as of Q4 2025, which was up 67400.0% from 41.03% recorded in Q3 2025.
  • Over the past 5 years, Amgen's EBT Margin peaked at 56.38% during Q1 2023, and registered a low of 0.91% during Q1 2024.
  • For the 5-year period, Amgen's EBT Margin averaged around 24.21%, with its median value being 24.89% (2022).
  • As far as peak fluctuations go, Amgen's EBT Margin soared by 295300bps in 2023, and later crashed by -572900bps in 2024.
  • Amgen's EBT Margin (Quarter) stood at 31.13% in 2021, then dropped by -18bps to 25.56% in 2022, then crashed by -59bps to 10.4% in 2023, then fell by -17bps to 8.61% in 2024, then skyrocketed by 78bps to 15.35% in 2025.
  • Its EBT Margin stands at 15.35% for Q4 2025, versus 41.03% for Q3 2025 and 17.08% for Q2 2025.